摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-benzyl-4-{4-oxo-2-[(2-oxo-2-{[(oxolan-2-yl)methyl]amino}ethyl)sulfanyl]quinazolin-3(4H)-yl}butanamide

中文名称
——
中文别名
——
英文名称
N-benzyl-4-{4-oxo-2-[(2-oxo-2-{[(oxolan-2-yl)methyl]amino}ethyl)sulfanyl]quinazolin-3(4H)-yl}butanamide
英文别名
N-benzyl-4-[4-oxo-2-[2-oxo-2-(oxolan-2-ylmethylamino)ethyl]sulfanylquinazolin-3-yl]butanamide
N-benzyl-4-{4-oxo-2-[(2-oxo-2-{[(oxolan-2-yl)methyl]amino}ethyl)sulfanyl]quinazolin-3(4H)-yl}butanamide化学式
CAS
——
化学式
C26H30N4O4S
mdl
——
分子量
494.6
InChiKey
KAGVUCBIIIEDGM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    35
  • 可旋转键数:
    11
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    125
  • 氢给体数:
    2
  • 氢受体数:
    6

文献信息

  • Chemical inhibition of the E3 ligase subunit FBXO7 confers neuroprotection and anti-inflammatory activity by stabilizing mitochondria
    申请人:University of Pittsburgh—Of the Commonwealth System of Higher Education
    公开号:US11242339B2
    公开(公告)日:2022-02-08
    A method for treating a neurodegenerative disease or an inflammatory disorder in a subject, comprising administering to the subject in need thereof, a compound, or a pharmaceutically acceptable salt thereof, of formula II: wherein each of R3-R7 is independently H, halogen, optionally-substituted alkyl, amino, alkoxy or hydroxy; R8 is an optionally-substituted heterocycloalkyl; and a is 0 to 3.
    一种治疗受试者的神经退行性疾病或炎症性疾病的方法,包括向有需要的受试者施用式 II 的化合物或其药学上可接受的盐: 其中R3-R7各自独立地为H、卤素、任选取代的烷基、基、烷氧基或羟基; R8 是任选取代的杂环烷基;以及 a 为 0 至 3。
  • CHEMICAL INHIBITION OF THE E3 LIGASE SUBUNIT FBXO7 CONFERS NEUROPROTECTION AND ANTI-INFLAMMATORY ACTIVITY BY STABILIZING MITOCHONDRIA
    申请人:University of Pittsburgh - Of the Commonwealth System of Higher Education
    公开号:US20200216426A1
    公开(公告)日:2020-07-09
    A method for treating a neurodegenerative disease or an inflammatory disorder in a subject, comprising administering to the subject in need thereof, a compound, or a pharmaceutically acceptable salt thereof, of formula II: wherein each of R 3 -R 7 is independently H, halogen, optionally-substituted alkyl, amino, alkoxy or hydroxy; R 8 is an optionally-substituted heterocycloalkyl; and a is 0 to 3.
  • [EN] CHEMICAL INHIBITION OF THE E3 LIGASE SUBUNIT FBX07 CONFERS NEUROPROTECTION AND ANTI-INFLAMMATORY ACTIVITY BY STABILIZING MITOCHONDRIA<br/>[FR] INHIBITION CHIMIQUE DE SOUS-UNITÉ DE LIGASE E3 FBX07 PROCURANT UNE NEUROPROTECTION ET UNE ACTIVITÉ ANTI-INFLAMMATOIRE PAR STABILISATION DES MITOCHONDRIES
    申请人:UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION
    公开号:WO2019005685A1
    公开(公告)日:2019-01-03
    A method for treating a neurodegenerative disease or an inflammatory disorder in a subject, comprising administering to the subject in need thereof, a compound, or a pharmaceutically acceptable salt thereof, of formula II: wherein each of R3-R7 is independently H, halogen, optionally-substituted alkyl, amino, alkoxy or hydroxy; R8 is an optionally-substituted heterocycloalkyl; and a is 0 to 3.
查看更多